Published in Rheumatology (Oxford) on August 20, 2009
Usefulness of anti-p155 autoantibody for diagnosing cancer-associated dermatomyositis: a systematic review and meta-analysis. Arthritis Rheum (2012) 2.08
Paraneoplastic vasculitis in patients with solid tumors: report of 15 cases. J Rheumatol (2007) 1.70
Tacrolimus in the treatment of chronic and refractory late-onset immune-mediated adverse effects related to silicone injections. Dermatol Surg (2011) 1.46
Delayed immune-mediated adverse effects of polyalkylimide dermal fillers: clinical findings and long-term follow-up. Arch Dermatol (2008) 1.41
The neural network as a predictor of cancer in patients with inflammatory myopathies. Arthritis Rheum (2002) 1.40
Erdheim-Chester disease. Ann Rheum Dis (2013) 1.40
[Neuropsyquiatric manifestations in systemic lupus erythematosus]. Med Clin (Barc) (2009) 1.39
Livedo racemosa as a marker of increased risk of recurrent thrombosis in patients with negative anti-phospholipid antibodies. Med Clin (Barc) (2009) 1.39
Occupational exposure in patients with the antisynthetase syndrome. Clin Rheumatol (2014) 1.37
Conventional cancer screening versus PET/CT in dermatomyositis/polymyositis. Am J Med (2010) 1.22
Implication of human endogenous retroviruses in the development of autoimmune diseases. Int Rev Immunol (2010) 1.18
Nailfold capillary microscopy in adults with inflammatory myopathy. Semin Arthritis Rheum (2008) 1.18
Effect of mycophenolate sodium in scleroderma-related interstitial lung disease. Clin Rheumatol (2011) 1.17
Genome-wide association study of dermatomyositis reveals genetic overlap with other autoimmune disorders. Arthritis Rheum (2013) 1.12
Efficacy and safety of lenalidomide for refractory cutaneous lupus erythematosus. Arthritis Res Ther (2012) 1.09
Molecular mechanisms mediated by human endogenous retroviruses (HERVs) in autoimmunity. Rev Med Virol (2009) 1.08
Risk, predictors, and clinical characteristics of lymphoma development in primary Sjögren's syndrome. Semin Arthritis Rheum (2011) 1.08
More on remission of recalcitrant dermatomyositis treated with ruxolitinib. N Engl J Med (2015) 1.05
Antihistone and anti-double-stranded deoxyribonucleic acid antibodies are associated with renal disease in systemic lupus erythematosus. Am J Med (2004) 1.05
DNA methylation and systemic lupus erythematosus. Ann N Y Acad Sci (2007) 1.00
GEMOX-R regimen is a highly effective salvage regimen in patients with refractory/relapsing diffuse large-cell lymphoma: a phase II study. Eur J Haematol (2007) 0.99
Anti-PL-7 (anti-threonyl-tRNA synthetase) antisynthetase syndrome: clinical manifestations in a series of patients from a European multicenter study (EUMYONET) and review of the literature. Medicine (Baltimore) (2012) 0.99
Transcript levels of DNA methyltransferases DNMT1, DNMT3A and DNMT3B in CD4+ T cells from patients with systemic lupus erythematosus. Immunology (2008) 0.97
No detection of parvovirus B19 or herpesvirus DNA in giant cell arteritis. J Clin Virol (2004) 0.97
Myositis-specific and myositis-associated antibodies in a series of eighty-eight Mediterranean patients with idiopathic inflammatory myopathy. Arthritis Rheum (2006) 0.94
Rates of, and risk factors for, severe infections in patients with systemic autoimmune diseases receiving biological agents off-label. Arthritis Res Ther (2011) 0.93
Cancer-associated myositis and anti-p155 autoantibody in a series of 85 patients with idiopathic inflammatory myopathy. Medicine (Baltimore) (2010) 0.92
Anti-TIF1γ antibodies (anti-p155) in adult patients with dermatomyositis: comparison of different diagnostic assays. Ann Rheum Dis (2012) 0.89
Transcript overexpression of the MBD2 and MBD4 genes in CD4+ T cells from systemic lupus erythematosus patients. J Leukoc Biol (2007) 0.89
Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status. Semin Arthritis Rheum (2011) 0.87
Celiac disease and antibodies associated with celiac disease in patients with inflammatory myopathy. Muscle Nerve (2007) 0.87
Serum levels of soluble CD40 ligand at flare and at remission in patients with systemic lupus erythematosus. J Rheumatol (2009) 0.86
The complex immunogenetic basis of systemic lupus erythematosus. Autoimmun Rev (2008) 0.86
Age-related survival and clinical features in systemic sclerosis patients older or younger than 65 at diagnosis. Rheumatology (Oxford) (2010) 0.82
Genetic risk factors of thrombosis in the antiphospholipid syndrome. Br J Haematol (2009) 0.82
Are bacterial growth and/or chemotaxis increased by filler injections? Implications for the pathogenesis and treatment of filler-related granulomas. Dermatology (2010) 0.82
Idiopathic retroperitoneal fibrosis: a clinicopathological study in 24 Spanish cases. Clin Rheumatol (2013) 0.81
Delayed immune-mediated adverse effects related to polyacrylamide dermal fillers: clinical findings, management, and follow-up. Dermatol Surg (2009) 0.81
Calcineurin inhibitors in a cohort of patients with antisynthetase-associated interstitial lung disease. Clin Exp Rheumatol (2013) 0.81
Assessment of the markers of platelet and coagulation activation following transcatheter closure of atrial septal defects. Int J Cardiol (2005) 0.80
Anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with idiopathic inflammatory myopathy. Rheumatology (Oxford) (2009) 0.80
DNASE I mutation and systemic lupus erythematosus in a Spanish population: comment on the article by Tew et al. Arthritis Rheum (2002) 0.79
Associations between the expression of epigenetically regulated genes and the expression of DNMTs and MBDs in systemic lupus erythematosus. PLoS One (2012) 0.79
Generalized muscle pseudo-hypertrophy and stiffness associated with the myotilin Ser55Phe mutation: a novel myotilinopathy phenotype? J Neurol Sci (2008) 0.79
Xenotropic murine leukemia virus-related virus (XMRV) in patients with systemic lupus erythematosus. J Clin Immunol (2011) 0.79
Venous thromboembolism in patients with dermatomyositis and polymyositis. Clin Exp Rheumatol (2011) 0.79
Health-related quality of life and well-being in adults with idiopathic inflammatory myopathy. Clin Rheumatol (2014) 0.78
A 79-year-old man with dyspnea, dysphagia, and weakness. Chest (2012) 0.78
[Polymyositis-dermatomyositis: incidence in Spain (1997-2004)]. Med Clin (Barc) (2007) 0.78
Idiopathic retroperitoneal fibrosis: IgG4 infiltration in a cohort of Spanish patients. Rheumatol Int (2014) 0.78
Clinical and serological findings associated with the expression of ITGAL, PRF1, and CD70 in systemic lupus erythematosus. Clin Exp Rheumatol (2013) 0.78
Obstructive sleep apnea in patients with inflammatory myopathies. Muscle Nerve (2009) 0.77
Changes in lipid profile between flare and remission of patients with systemic lupus erythematosus: a prospective study. J Rheumatol (2009) 0.77
[Atherosclerosis and anti-oxidized low density lipoprotein antibodies in an elderly population]. Med Clin (Barc) (2002) 0.76
Correlation of ultrasound B-lines with high-resolution computed tomography in antisynthetase syndrome. Clin Exp Rheumatol (2014) 0.76
[Clinical features and prognosis of patients with scleroderma renal crisis]. Med Clin (Barc) (2011) 0.75
A 21-year-old girl with recurrent abdominal pain after a robbery. Lancet (2005) 0.75
Intravascular large B-cell lymphoma, a cause of fever of unknown origin in the elderly. J Am Geriatr Soc (2012) 0.75
Nephrotic syndrome and lambda light-chain monoclonal gammopathy suggestive of primary amyloidosis with positive staining for AA amyloid. J Am Geriatr Soc (2012) 0.75
Mixed Connective Tissue Disease and Epitope Spreading: An Historical Cohort Study. J Clin Rheumatol (2017) 0.75
[Erdheim-Chester disease: study of 12 cases]. Med Clin (Barc) (2012) 0.75
Enhanced transcript levels of CD48 in CD4⁺ T cells from systemic lupus erythematosus patients. Immunobiology (2011) 0.75
New Autoantibodies in Inflammatory Myopathies: Diagnostic Value and Relationship with Clinical Phenotypes. Isr Med Assoc J (2015) 0.75